Biometric Identification and Cybersecurity Software Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conference at 11:30am ET, Jan. 28 in Atlantic City, NJ

Rhea-AI Summary

BIO-key (NASDAQ:BKYI) will present at the DealFlow Discovery investor conference at the Borgata in Atlantic City on Jan. 28–29, 2026. CEO Mike DePasquale is scheduled to present on Jan. 28 at 11:30am ET in Room 1 and will be available for 1-on-1 investor meetings during the event. Institutional investors, family offices, and high-net-worth investors may register at no cost. Presentation materials will be posted on the DealFlow Discovery website in January and registration is available online.

News Market Reaction

-4.09%

1 alert

-4.09% News Effect

-$277K Valuation Impact

$7M Market Cap

0.1x Rel. Volume

On the day this news was published, BKYI declined 4.09%, reflecting a moderate negative market reaction. This price movement removed approximately $277K from the company's valuation, bringing the market cap to $7M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference dates: January 28–29, 2026 Presentation time: 11:30 am ET Presentation room: Room 1 +3 more

6 metrics

Conference dates January 28–29, 2026 DealFlow Discovery Conference schedule at Borgata hotel

Presentation time 11:30 am ET BIO-key CEO presentation slot on January 28

Presentation room Room 1 Location of BIO-key’s DealFlow conference session

Price change 4.62% BKYI move over prior 24 hours before this news

52-week range $0.5088–$3.68 Low and high before this announcement

Market cap $6,209,382 Equity value prior to conference news

Market Reality Check

Price: $0.5925 Vol: Volume 124,018 vs 20-day ...

low vol

$0.5925 Last Close

Volume Volume 124,018 vs 20-day average 209,447 suggests muted trading interest ahead of the event. low

Technical Price 0.5995 is trading below the 200-day MA at 0.77, indicating a longer-term downtrend pre-news.

Peers on Argus

BKYI was up 4.62% while peers showed mixed moves: SUGP up 14.33%, IVDA down 4.56...

BKYI was up 4.62% while peers showed mixed moves: SUGP up 14.33%, IVDA down 4.56%, GFAI down 2.4%, SPCB down 2.72%, VRME roughly flat at 0.2%, pointing to stock-specific rather than broad sector momentum.

Historical Context

5 past events · Latest: Dec 23 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 23	Conference participation	Neutral	-0.8%	Announced upcoming DealFlow Discovery investor conference appearance.
Dec 08	Industry conference	Positive	+0.6%	Showcased new passwordless authentication innovations at Gartner IAM Summit.
Nov 17	Strategic partnership	Positive	+2.9%	Partnered with SAVIS Group to distribute biometric solutions in Vietnam.
Nov 14	Earnings and update	Negative	-2.4%	Reported lower year-over-year revenue and a quarterly net loss.
Nov 12	Strategic partnership	Positive	+11.3%	Teamed with VaporVM to expand IAM and biometric reach in MEA.

Pattern Detected

Recent news, including partnerships and conference appearances, has generally seen price reactions align with the underlying news tone.

Recent Company History

Over the last few months, BIO-key has combined investor outreach with strategic execution. The company announced multiple partnerships in November 2025 to expand biometric and IAM solutions across Vietnam and the Middle East/Africa, with one partnership coinciding with an 11.31% gain. Q3 2025 results on Nov 14 showed revenue of $1,548,706, a $964,849 net loss, and $2.04M cash, alongside new product launches and financing activity. A prior DealFlow conference announcement on Dec 23, 2025 had a modest -0.83% reaction, framing today’s follow-up as part of ongoing investor engagement.

Market Pulse Summary

This announcement extends BIO-key’s ongoing investor outreach by confirming the specific presentatio...

Analysis

This announcement extends BIO-key’s ongoing investor outreach by confirming the specific presentation slot at the DealFlow Discovery Conference on January 28–29, 2026. In recent months the company paired such visibility efforts with strategic partnerships and Q3 2025 results, which included revenue of $1,548,706 and cash of $2.04M. Regulatory filings also detailed warrant exercises and registration activity. Investors may track future updates on revenue progress, capital structure changes, and any follow-up from conference meetings.

Key Terms

biometric, identity and access management, saas, passwordless, +1 more

5 terms

biometric technical

"a leading provider of biometric enabled Identity and Access Management SaaS solutions"

Biometric describes measurements of unique physical or behavioral traits—like fingerprints, face shape, voice, or the way someone types—used to identify or verify a person. For investors, biometrics matter because they underpin products and services that promise stronger security or convenience, create new market opportunities, and raise regulatory and privacy risks that can affect a company’s costs, customer trust, and long-term value.

identity and access management technical

"provider of biometric enabled Identity and Access Management SaaS solutions"

Identity and access management is the set of tools and processes that verify who a person or device is and control what digital resources they can use, like a company’s system for issuing security badges and setting which doors each badge opens. It matters to investors because strong identity controls reduce the chance of costly data breaches, regulatory fines and downtime, protect customer trust, and can lower IT costs and operational risk.

saas technical

"Identity and Access Management SaaS solutions for phoneless, tokenless, passwordless"

SaaS, or Software as a Service, is a way of delivering computer programs over the internet, allowing users to access and use them through a web browser without needing to install or maintain the software themselves. For investors, it highlights a business model where companies generate recurring revenue by providing ongoing access to their software, often leading to predictable income and growth potential.

passwordless technical

"solutions for phoneless, tokenless, passwordless, and phish-resistant authentication"

Passwordless describes authentication methods that let users access accounts without typing a traditional password, using alternatives like a fingerprint, a one-time code, a security key, or a trusted device instead. For investors, it matters because replacing passwords can cut security breach risk, lower customer support and compliance costs, and improve user conversion — like replacing fragile paper tickets with a secure, easy-to-scan digital pass that reduces theft and lines.

phish-resistant authentication technical

"solutions for phoneless, tokenless, passwordless, and phish-resistant authentication"

Authentication designed to stop phishing uses login methods that cannot be fooled by fake emails or websites, such as physical tokens, device-based cryptographic checks, or biometric confirmations that verify both the user and the real service. For investors, phish-resistant authentication lowers the chance of costly security breaches, reduces legal and cleanup costs, and protects customer trust and company value — like a lock that rejects copied keys.

AI-generated analysis. Not financial advice.

ATLANTIC CITY & HOLMDEL, NJ / ACCESS Newswire / January 13, 2026 / BIO-key® International, Inc. (NASDAQ:BKYI), a leading provider of biometric enabled Identity and Access Management SaaS solutions for phoneless, tokenless, passwordless, and phish-resistant authentication, will participate at the DealFlow Discovery Conference Wednesday and Thursday, January 28th and 29th at the Borgata hotel in Atlantic City, New Jersey. Institutional investors, family offices and high-net-worth investors are invited to attend at no cost.

BIO-key CEO Mike DePasquale will present on Wednesday at 11:30 am ET in Room 1 and will be available for 1-on-1 meetings throughout the event. BIO-key's presentation details will be posted on DealFlow's website in January.

Registration:

Click here: https://dealflowdiscoveryconference.com/registration/ to register for the Discovery Conference.

About The DealFlow Discovery (www.dealflowdiscoveryconference.com)

The DealFlow Discovery Conference is where high-growth companies come to be discovered. Formerly known as The Microcap Conference, the event has been expanded to include both publicly traded microcaps and qualified private companies across a variety of high-growth sectors.

Organized by DealFlow Events, the conference brings together hundreds of companies, investors, and dealmakers for two days of company presentations, expert discussions on raising capital, unlimited 1-on-1 meetings, interactive sessions and networking opportunities. The Discovery Conference delivers a high visibility platform for companies to showcase their value propositions to a broad base of prospective investors.

Keynote presentations and panel discussions led by renowned industry figures will provide insights on business, investing, entrepreneurial success, and other trends in US equity markets, from capital formation to regulatory updates, tailored to the public microcap and private market communities.

About BIO-key International, Inc. (www.BIO-key.com)

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

Engage with BIO-key:

LinkedIn - Corporate: https://www.linkedin.com/company/bio-key-international

X - Corporate: @BIOkeyIntl

X - Investors: @BIO_keyIR

StockTwits: BIO_keyIR

Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800

SOURCE: DealFlow Events

View the original press release on ACCESS Newswire

FAQ

When and where will BIO-key (BKYI) present at the DealFlow Discovery conference?

BIO-key will present at the Borgata in Atlantic City on Jan. 28, 2026 at 11:30am ET during the DealFlow Discovery conference.

Who from BIO-key will present at the Jan. 28, 2026 DealFlow event for BKYI?

CEO Mike DePasquale will deliver the BIO-key presentation and is available for 1-on-1 investor meetings.

How can investors register for the DealFlow Discovery conference where BKYI will present?

Investors can register at no cost via the DealFlow Discovery registration page: https://dealflowdiscoveryconference.com/registration/.

Will BIO-key (BKYI) make presentation materials available from the Jan. 28, 2026 DealFlow conference?

Presentation details and materials will be posted on the DealFlow Discovery website in January.

Can institutional investors meet privately with BIO-key management at the DealFlow Discovery event?

Yes; the CEO will be available for 1-on-1 investor meetings throughout the conference on Jan. 28–29, 2026.